• ProMIS Neurosciences held its annual shareholder meeting on May 20, 2026.
• Shareholders backed an amendment to the 2025 Stock Option and Incentive Plan, increasing the share pool available for issuance under the plan by 900,000 shares; the amendment became effective upon that approval.
• The appointment of Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026 was ratified.
• Director nominees were elected to serve until the 2027 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProMIS Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-064545), on May 20, 2026, and is solely responsible for the information contained therein.